There has recently been an important step towards treating HIV. A new experimental vaccine has been tested in human trials. The vaccine was developed by the International AIDS Vaccine Initiative (IAVI) and Scripps Research. The vaccines are developed to trigger the production of rare immune cells that can destroy HIV. The initial results are promising — 97% of those that received the vaccine generated HIV-fighting antibodies.